Key points are not available for this paper at this time.
We show that IBC is transcriptionally heterogeneous and that all molecular subtypes described in nIBC are detectable in IBC, albeit with a different frequency. The molecular profile of IBC, bearing molecular traits of aggressive breast tumor biology, shows attenuation of TGF-β signaling, potentially explaining the metastatic potential of IBC tumor cells in an unexpected manner.
Building similarity graph...
Analyzing shared references across papers
Loading...
Steven Van Laere
Naoto T. Ueno
Pascal Finetti
Clinical Cancer Research
Inserm
The University of Texas MD Anderson Cancer Center
KU Leuven
Building similarity graph...
Analyzing shared references across papers
Loading...
Laere et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d946e49402b8412aa3cca1 — DOI: https://doi.org/10.1158/1078-0432.ccr-12-2549
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: